Mml Investors Services, LLC Bristol Myers Squibb CO Transaction History

Mml Investors Services, LLC

$24.3 Billion
Q1 2024

A detailed history of Mml Investors Services, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mml Investors Services, LLC holds 390,548 shares of BMY stock, worth $16.2 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

390,548

Previous 300,162 30.11%

Holding current value

$16.2 Million

Previous $15.4 Million 37.52%

% of portfolio

0.09%

Previous 0.07%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $4.34 Million - $4.92 Million	90,386 Added 30.11%	390,548 $21.2 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $3.43 Million - $4.09 Million	-70,752 Reduced 19.08%	300,162 $15.4 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $3.73 Million - $4.17 Million	-64,494 Reduced 14.81%	370,914 $21.5 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $1.07 Million - $1.18 Million	16,717 Added 3.99%	435,408 $27.8 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $650,594 - $737,921	9,901 Added 2.42%	418,691 $29 Million

Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $1.46 Million - $1.73 Million	21,331 Added 5.51%	408,790 $29.4 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $2,785 - $1.65 Million	-21,427 Reduced 5.24%	387,459 $27.5 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $290,552 - $319,999	-4,001 Reduced 0.97%	408,886 $31.5 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $6.32 Million - $7.58 Million	102,867 Added 33.18%	412,887 $30.2 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $5.96 Million - $6.95 Million	-111,148 Reduced 26.39%	310,020 $19.3 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $3.39 Million - $3.97 Million	57,325 Added 15.76%	421,168 $24.9 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $1.09 Million - $1.19 Million	17,651 Added 5.1%	363,843 $24.3 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $2.69 Million - $3.03 Million	45,380 Added 15.09%	346,192 $21.9 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $1.92 Million - $2.17 Million	33,179 Added 12.4%	300,812 $18.7 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $4.45 Million - $4.93 Million	77,537 Added 40.79%	267,633 $16.1 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $2.35 Million - $2.75 Million	42,931 Added 29.17%	190,096 $11.2 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $1.07 Million - $1.55 Million	23,037 Added 18.56%	147,165 $8.2 Million
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $1.36 Million - $1.77 Million	27,608 Added 28.6%	124,128 $7.97 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $2.37 Million - $2.8 Million	-55,296 Reduced 36.42%	96,520 $4.9 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $461,638 - $510,471	10,346 Added 7.31%	151,816 $6.89 Million
Q1 2019 May 10, 2019	SELL	$45.12 - $53.8 $8,798 - $10,491	-195 Reduced 0.14%	141,470 $6.75 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $2.74 Million - $3.55 Million	56,128 Added 65.62%	141,665 $7.36 Million
Q3 2018 Nov 07, 2018	BUY	$55.19 - $62.25 $1.1 Million - $1.24 Million	19,898 Added 30.31%	85,537 $5.31 Million
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $117,583 - $146,554	-2,327 Reduced 3.42%	65,639 $3.63 Million
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $840,977 - $968,134	-14,035 Reduced 17.12%	67,966 $4.3 Million
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $1.46 Million - $1.59 Million	-24,368 Reduced 22.91%	82,001 $5.03 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $5.87 Million - $6.78 Million	106,369	106,369 $6.78 Million

Others Institutions Holding BMY

# of Institutions

2,554

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $88.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.

Account

Mml Investors Services, LLC Bristol Myers Squibb CO Transaction History